Septic Shock: Diagnosis, Treatment, and Monitoring

May 29, 2024

Septic Shock: Diagnosis, Treatment, and Monitoring

Overview

  • Septic shock: Infection in the bloodstream leading to a severe immune response.
  • Initial response: WBCs release immune molecules causing damage and increased permeability and diameter of blood vessels.

Diagnosis

Symptoms to Watch For

  • Fevers, chills, sweating, flushed appearance
  • Dropping blood pressure

Diagnostic Steps

  1. Vital signs: Check temperature and other vital signs.
  2. Blood cultures: Identify infective material (fungus, bacteria, virus).
  3. Severity assessment: Measure serum lactate, arterial blood gas (ABG), BUN, and Creatinine.
    • Serum Lactate: Indicates tissue perfusion and anaerobic metabolism.
    • ABG: Measures oxygen, carbon dioxide levels in the blood.
    • BUN & Creatinine: Assess kidney function and detect early damage due to lack of oxygen.

Treatment

  • Prompt treatment: Reduces mortality.
  • Broad spectrum antibiotics: To address a wide range of infections initially.
    • If patient shows no improvement, consider anti-fungals.
  • IV fluids: To restore blood pressure.
  • Pressors: Medications used to increase systemic vascular resistance and blood pressure.
  • Tailored therapy: Based on blood culture results.

Key Points

  • Always draw blood cultures before starting antibiotics to avoid interfering with culture growth.
  • Treatment should not be delayed as it can lead to increased mortality.
  • Use of two large bore IV lines may be necessary for rapid fluid infusion.

Monitoring Progress

  • Repeated lactate, ABG, BUN, and Creatinine tests to track improvement.
  • CRP and ESR: Track inflammation.
    • Normal CRP: <1 mg/dL; normal ESR: <20-25 mm/hr depending on age.
    • Elevated in septic shock, should decrease as condition improves.

Final Points

  • Diagnosis, treatment, and monitoring are crucial.
  • Immediate blood cultures, followed by antibiotics.
  • Ensure rapid administration of IV fluids via large bore IV lines.